Venetoclax Combo Reaches High CR Rate in Older AML Patients
Published: Wednesday, Dec 20, 2017
Andrew Wei, MBBS, PhD
Two-thirds of older patients with acute myeloid leukemia (AML) achieved complete responses with the combination of venetoclax (Venclexta) and cytarabine, according to results from a phase I/II trial.
... to read the full story